Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline with bone-targeted therapy in metastatic breast cancer
NCT01847976Phase 2Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Aug 2013
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in breast cancer, sponsored by Ottawa Hospital Research Institute. Started Aug 2013; status: completed.
02
Drugs
doxycycline
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01847976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01847976.